U.S Representatives Michael C. Burgess, MD, R–Texas, and Ron Kind, D–Wis., have introduced HR 1325, the Immunosuppressive Drug Coverage for Kidney Transplant Patients Act, which would extend coverage of anti-rejection drugs for kidney transplant recipients. This legislation would allow individuals who are eligible for immunosuppressive drugs under Medicare Part B to continue to receive theirRead more